193 related articles for article (PubMed ID: 18998457)
1. [Candidate targets for research on benign prostatic hyperplasia].
Hong ZF
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):771-4. PubMed ID: 18998457
[TBL] [Abstract][Full Text] [Related]
2. Pathology of benign prostatic hyperplasia.
Roehrborn CG
Int J Impot Res; 2008 Dec; 20 Suppl 3():S11-8. PubMed ID: 19002119
[TBL] [Abstract][Full Text] [Related]
3. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Horton R
Am J Nephrol; 1982; 2(3):157-63. PubMed ID: 6184994
[No Abstract] [Full Text] [Related]
4. [Histologic components of benign prostatic hypertrophy (bph) in relation to the androgen-estrogen status (author's transl)].
Seppelt U; Buhl K; Drews M
Urologe A; 1978 Mar; 17(2):117-9. PubMed ID: 76360
[TBL] [Abstract][Full Text] [Related]
5. Androgens and estrogens in prostatic neoplasia.
Mawhinney MG; Belis JA
Adv Sex Horm Res; 1976; 2():141-209. PubMed ID: 65116
[No Abstract] [Full Text] [Related]
6. [The etiology of benign prostatic hyperplasia--recent findings].
Lindner UA; Zisman A; Lindner A
Harefuah; 1999 Jan; 136(2):161-4. PubMed ID: 10914188
[No Abstract] [Full Text] [Related]
7. Common characteristics of human and canine benign prostatic hyperplasia.
Isaacs JT
Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
[No Abstract] [Full Text] [Related]
8. Etiology of benign prostatic hyperplasia.
Lee C; Kozlowski JM; Grayhack JT
Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
Magyarsóky F
Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
[No Abstract] [Full Text] [Related]
10. Human benign prostatic hyperplasia: etiological considerations.
Walsh PC
Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
[No Abstract] [Full Text] [Related]
11. [Chronic congestion as genesis of the prostatic adenoma, secondary hormonal changes].
Hak-Hagir A
Z Urol Nephrol; 1976 Apr; 69(4):275-8. PubMed ID: 60015
[No Abstract] [Full Text] [Related]
12. [Metabolism and conjugation of steroid hormones: their active metabolites and prehormone-hormone relationship].
Kato T
Nihon Rinsho; 1984 Nov; 42(11):2452-8. PubMed ID: 6085118
[No Abstract] [Full Text] [Related]
13. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia].
Tørring N; Nexø E
Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708
[No Abstract] [Full Text] [Related]
14. Free estrogens and progestogens in benign prostatic hypertrophy.
Narayan JP; Srivastava SP; Singh JN
Indian J Physiol Pharmacol; 1985; 29(2):119-22. PubMed ID: 2419249
[TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia in the nonhuman primate.
Lewis RW
Prog Clin Biol Res; 1984; 145():235-55. PubMed ID: 6201877
[No Abstract] [Full Text] [Related]
16. [Estrogen and estrogen receptors in benign prostatic hyperplasia].
Wu JQ; Gao X
Zhonghua Nan Ke Xue; 2002; 8(3):212-4. PubMed ID: 12478848
[TBL] [Abstract][Full Text] [Related]
17. [Histologic forms of benign prostatic hyperplasia: focus on fibroblastic factors].
Cussenot O
Ann Urol (Paris); 2006 Mar; 40 Spec No 1():4-6. PubMed ID: 16649582
[No Abstract] [Full Text] [Related]
18. [Growth factors and benign prostatic hyperplasia].
Boroian R
Georgian Med News; 2007 Nov; (152):18-22. PubMed ID: 18175827
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal changes in elderly men with prostatic adenoma].
Lopatkin NA; Goriunov VG; Domurat B
Vestn Akad Med Nauk SSSR; 1980; (3):72-7. PubMed ID: 6156551
[No Abstract] [Full Text] [Related]
20. Pathogenesis of prostatic hyperplasia and neoplasia.
Roberts HJ
Geriatrics; 1967 Dec; 22(12):85-92. PubMed ID: 4168607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
